Ever wonder why giant pharmaceutical companies spend billions buying up smaller biotech firms? It's not just about money; it's a strategic move shaping the future of medicine. This lesson reveals the crucial role these acquisitions play in bringing groundbreaking drugs to market faster and what it means for healthcare innovation.
Did you know big pharma spent over $200 billion on biotech acquisitions in 2023 alone?